Wockhardt
May 27, 2012 at 11:52 | Source: CNBC-TV18
May 26, 2012 at 11:12 | Source: Moneycontrol.com
May 26, 2012 at 08:36 | Source: Moneycontrol.com
May 24, 2012 at 12:46 | Source: Moneycontrol.com
May 24, 2012 at 09:07 | Source: CNBC-TV18
May 23, 2012 at 16:49 | Source: CNBC-TV18
News across the web »
May 28, 2012 at 04:51 | Source: Economic Times
May 26, 2012 at 22:27 | Source: Economic Times
May 25, 2012 at 10:06 | Source: FirstPost
May 24, 2012 at 13:21 | Source: FirstPost
May 23, 2012 at 18:03 | Source: FirstPost
Interact & exchange stock tips & market info »
Related News »
Mumbai: Drug maker Wockhardt Ltd swung to a net loss in the three months ended 31 March, from a net profit a year earlier, on account of debt repayments and foreign exchange losses, the company said on Tuesday. The company lost Rs 192 crore in the quarter ...
May 22, 2012 at 17:12 | Source: Livemint.com
33840 Investors following Titan Ind. Share this News with them. Sudarshan Sukhani, s2analytics.com view is of the view that Titan Industries is a sell while he also added it is not an easy to buy Wockhardt at current level one has to be patient ...
May 24, 2012 at 08:19 | Source: MoneyControl.com
Ventura is bullish on Wockhardt and has recommended buy rating on the stock with a target of Rs 885 in its May 22, 2012 research report. “Wockhardt, net sales for the quarter stood at Rs 1241.4 crore v/s Rs 938.7 crore, registering a strong ...
May 26, 2012 at 05:25 | Source: MoneyControl.com
Drug firm Wockhardt today reported a consolidated net loss of Rs 191.64 crore for the quarter ended March 31, 2012 burdened by exceptional items. The company had posted a net profit of Rs 161.83 crore for the corresponding quarter previous fiscal.
May 22, 2012 at 11:35 | Source: Business Standard
(RTTNews) - Wockhardt Ltd., a global pharmaceutical and biotechnology company, reported net loss for the quarter on consolidated basis, hurt by higher expenses towards dispute settlement, provision for CDR recompense, impairment of goodwill. On a stand ...
May 22, 2012 at 09:48 | Source: RTT News
REUTERS - Drugmakers Ind-Swift (INSW.NS) and Wockhardt (WCKH.NS) have jointly launched a generic version of Pfizer's (PFE.N) cholesterol lowering drug Lipitor in the United Kingdom, the two companies said. The copycat version was launched on the ...
May 17, 2012 at 04:31 | Source: Reuters India
May 17 (Reuters) - Indian drugmakers Ind-Swift and Wockhardt have jointly launched a generic version of Pfizer's cholesterol lowering drug Lipitor in the United Kingdom, the two companies said. The copycat version was launched on the first day ...
May 17, 2012 at 03:34 | Source: Reuters
The Sensex and the Nifty lost all their morning gains and faced almost 1 percent cuts as the rupee touched all time low of Rs 55.36 against the dollar. The rupee dipped as Japan’s sovereign rating was cut by one notch by Fitch. Fitch warned ...
May 22, 2012 at 10:38 | Source: firstpost.com
Ind-Swift Ltd, a Chandigarh based pharmaceutical company, has launched generic formulations of the world's best selling drug atorvastatin in UK in collaboration with Wockhardt UK Ltd on the first day of its patent expiry. Atorvastatin, is the best selling ...
May 17, 2012 at 06:33 | Source: pharmabiz.com
It has received approval for its product in the strength of 0.1 per cent (137 mcg/spray). Wockhardt hits lifetime high, soars 14% post Q4 results 23-MAY-12 Wockhardt Limited has rallied 6% to Rs 762, also its lifetime high, in an other wise weak market ...
May 27, 2012 at 06:57 | Source: Business Standard